Fu Pengbo's latest heavy position stock exposure

On July 17th, Ruoyuan Fund's public fund product disclosed its second quarter report for 2025. In the second quarter of this year, the Hong Kong stock position of Ruoyuan Growth Value, jointly managed by well-known fund managers Fu Pengbo and Zhu Lin, increased from 25.97% to 27.35%. In terms of specific holdings, Xinyisheng entered the top ten heavy positions of the fund. In addition, the fund increased its holdings in Luxshare Precision, Hanwei Semiconductor, and Juxing Technology, while reducing its holdings in Sheng Hong Technology, Tencent Holdings, Ningde Times, China Mobile, Sanuo Biology, and Maiwei Technology. Fu Pengbo and Zhu Lin stated in the second quarter report that the net value contribution of the fund's Hong Kong and PCB targets was significant in the second quarter, with a focus on the overall allocation of electronics, internet technology, precision manufacturing, and pharmaceutical sectors. Compared to the first quarter, the gains of individual stocks in the PCB industry chain in the top ten holdings were significant, with their proportion significantly increasing. In addition, the fund also increased its allocation in the pharmaceutical sector, involving sub-industries such as innovative drugs and traditional Chinese medicine benefiting from AI.